PARNAXLABPharmaceuticals

Parnax Lab LtdQuarterly Results & Earnings

128.55
-2.85%
Profit Growth YoY6.45%Latest quarter
Sales Growth YoY29.45%Latest quarter
Sales CAGR 5Y14.52%5 year compound
Profit CAGR 5Y43.21%5 year compound
📋

Quarterly Performance

YoY Profit Growth+6.45%
📈 Moderate growth
YoY Sales Growth+29.45%
🔥 Exceptional growth
OPM 5Y Average
Operating profit margin
13.36%
EPS Growth 5Y
37.86%
Interest Coverage
Higher = safer debt servicing
3.94
ROE
15.14%
ROCE
13.97%
💡

Growth Analysis

Parnax Lab Ltd reported YoY profit growth of 6.45% and revenue growth of 29.45% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 14.52% and profits at 43.21% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.